ID28028A - Zat-zat farmasi untuk pengobatan penyakit parkinson, adhd dan mikroadenomas - Google Patents

Zat-zat farmasi untuk pengobatan penyakit parkinson, adhd dan mikroadenomas

Info

Publication number
ID28028A
ID28028A IDW20010637A ID20010637A ID28028A ID 28028 A ID28028 A ID 28028A ID W20010637 A IDW20010637 A ID W20010637A ID 20010637 A ID20010637 A ID 20010637A ID 28028 A ID28028 A ID 28028A
Authority
ID
Indonesia
Prior art keywords
microadenomas
adhd
parkinson
treatment
pharmaceutical substances
Prior art date
Application number
IDW20010637A
Other languages
English (en)
Inventor
Elise Rose Jackson
Stafford Mclean
Stevin Howard Zorn
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID28028A publication Critical patent/ID28028A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW20010637A 1998-09-21 1999-09-03 Zat-zat farmasi untuk pengobatan penyakit parkinson, adhd dan mikroadenomas ID28028A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10119198P 1998-09-21 1998-09-21
US10386898P 1998-10-12 1998-10-12

Publications (1)

Publication Number Publication Date
ID28028A true ID28028A (id) 2001-05-03

Family

ID=26798000

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010637A ID28028A (id) 1998-09-21 1999-09-03 Zat-zat farmasi untuk pengobatan penyakit parkinson, adhd dan mikroadenomas

Country Status (38)

Country Link
US (2) US6300329B1 (id)
EP (1) EP1115402A1 (id)
JP (1) JP2002526448A (id)
KR (3) KR20030088512A (id)
CN (1) CN1319013A (id)
AP (1) AP1456A (id)
AR (1) AR029739A1 (id)
AU (1) AU760230B2 (id)
BG (1) BG105445A (id)
BR (1) BR9913975A (id)
CA (1) CA2344670A1 (id)
CO (1) CO5140075A1 (id)
CZ (1) CZ20011006A3 (id)
DZ (1) DZ2894A1 (id)
EA (2) EA200100204A1 (id)
EE (1) EE200100179A (id)
GE (1) GEP20033081B (id)
GT (1) GT199900154A (id)
HN (1) HN1999000146A (id)
HR (1) HRP20010209A2 (id)
HU (1) HUP0103691A3 (id)
ID (1) ID28028A (id)
IL (2) IL164839A0 (id)
IS (1) IS5852A (id)
MA (1) MA26690A1 (id)
MY (1) MY127939A (id)
NO (1) NO20011409L (id)
NZ (1) NZ509855A (id)
OA (1) OA11653A (id)
PA (1) PA8482001A1 (id)
PE (1) PE20001084A1 (id)
PL (1) PL346904A1 (id)
SK (1) SK3592001A3 (id)
TN (1) TNSN99177A1 (id)
TR (2) TR200402083T2 (id)
TW (1) TW518225B (id)
WO (1) WO2000016777A1 (id)
YU (1) YU21701A (id)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1999000146A (es) * 1998-09-21 2000-11-11 Pfizer Prod Inc Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas.
WO2001068104A1 (en) * 2000-03-16 2001-09-20 The Mclean Hospital Corporation Compounds for the treatment of psychiatric or substance abuse disorders
GB0027020D0 (en) * 2000-11-03 2000-12-20 Univ Manchester Treatment of movement disorders
US7053092B2 (en) 2001-01-29 2006-05-30 Otsuka Pharmaceutical Co., Ltd. 5-HT1a receptor subtype agonist
WO2002102988A2 (en) * 2001-06-18 2002-12-27 Psychiatric Genomics, Inc. Method for neural stem cell differentiation using 5ht-1a agonists
US20030036555A1 (en) * 2001-08-03 2003-02-20 Boehringer Ingelheim Pharma Kg Pramipexole for the treatment of ADHD
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
WO2005122767A1 (en) * 2004-06-10 2005-12-29 Mclean Hospital Corporation Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
US7947661B2 (en) * 2004-08-11 2011-05-24 The Mclean Hospital Corporation Compounds for the treatment of marihuana dependence, withdrawal, and usage
MY148644A (en) 2005-07-18 2013-05-15 Orion Corp New pharmaceutical compounds
PE20070523A1 (es) 2005-09-12 2007-06-28 Wyeth Corp Formulacion de liberacion sostenida del glucuronato de (8-{4-[3-(5-fluoro-1h-indol-3-il)-propil]-piperazin-1-il}-2-metil-4h-benzo[1,4]oxazin-3-ona
GT200600414A (es) 2005-09-12 2007-09-20 Sal de glucuranato de compuesto de piperazine
GT200600416A (es) 2005-09-12 2007-09-20 Sales salicilato y gentisato de un compuesto de piperazina
US9066903B2 (en) * 2006-02-28 2015-06-30 The United States Of America As Represented By The Department Of Veterans Affairs Pharmacological treatment of Parkinson's disease
US20080131492A1 (en) * 2006-06-23 2008-06-05 Spherics, Inc. Dosage forms for movement disorder treatment
WO2008083442A1 (en) * 2007-01-10 2008-07-17 Brc Operations Pty Limited Method for formulating combination medications for adhd
CN101318020B (zh) * 2007-06-06 2011-09-28 四川科瑞德制药有限公司 抗焦虑或/和抗抑郁的药物组合物及用途
US20100041621A1 (en) * 2008-08-15 2010-02-18 Perry Renshaw Methods and compositions for improving cognitive performance
GB201112987D0 (en) 2011-07-28 2011-09-14 Ge Healthcare Ltd Novel compound
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
US9463186B2 (en) 2013-04-15 2016-10-11 Northwestern University Treatment for dopaminergic disorders
CN104892589A (zh) 2014-03-07 2015-09-09 中国科学院上海药物研究所 一类杂环化合物、其制备方法和用途
US11426366B2 (en) 2015-05-15 2022-08-30 Arizona Board Of Regents On Behalf Of The Universsity Of Arizona Compositions and methods for treating motor disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents
WO1992000075A1 (en) * 1990-06-29 1992-01-09 Pfizer Inc. Pyridopyrazine derivatives for treating substance abuse and addiction
US5281607B1 (en) * 1992-10-08 1998-05-19 Univ New York Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases
GB9408084D0 (en) * 1994-04-23 1994-06-15 Boots Co Plc Medical treatment
WO1995034555A1 (en) * 1994-06-14 1995-12-21 Pfizer Inc. Benzimidazolone derivatives with central dopaminergic activity
US5877183A (en) * 1996-06-06 1999-03-02 Ergo Research Corporation Treatment of lipid and glucose metabolism disorders with dopamine and serotonin agonists
HN1999000146A (es) * 1998-09-21 2000-11-11 Pfizer Prod Inc Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas.

Also Published As

Publication number Publication date
TR200101357T2 (tr) 2001-08-21
IL164839A0 (en) 2005-12-18
TNSN99177A1 (fr) 2005-11-10
HRP20010209A2 (en) 2002-04-30
KR20030088512A (ko) 2003-11-19
EA200100204A1 (ru) 2001-08-27
PL346904A1 (en) 2002-03-11
BR9913975A (pt) 2001-06-19
CN1319013A (zh) 2001-10-24
NO20011409D0 (no) 2001-03-20
US20010034347A1 (en) 2001-10-25
WO2000016777A1 (en) 2000-03-30
PA8482001A1 (es) 2000-05-24
KR100468340B1 (ko) 2005-01-27
BG105445A (en) 2001-12-29
EE200100179A (et) 2002-10-15
EP1115402A1 (en) 2001-07-18
HUP0103691A3 (en) 2003-01-28
US6300329B1 (en) 2001-10-09
IS5852A (is) 2001-02-20
YU21701A (sh) 2004-07-15
US6608064B2 (en) 2003-08-19
PE20001084A1 (es) 2000-10-18
TW518225B (en) 2003-01-21
AU5383199A (en) 2000-04-10
MA26690A1 (fr) 2004-12-20
KR20040054752A (ko) 2004-06-25
GEP20033081B (en) 2003-10-27
KR20010075222A (ko) 2001-08-09
AR029739A1 (es) 2003-07-16
HN1999000146A (es) 2000-11-11
DZ2894A1 (fr) 2003-12-15
CO5140075A1 (es) 2002-03-22
GT199900154A (es) 2001-03-06
SK3592001A3 (en) 2001-12-03
TR200402083T2 (tr) 2004-10-21
IL141507A0 (en) 2002-03-10
EA200301063A1 (ru) 2004-12-30
CZ20011006A3 (cs) 2001-09-12
JP2002526448A (ja) 2002-08-20
NZ509855A (en) 2003-04-29
CA2344670A1 (en) 2000-03-30
AU760230B2 (en) 2003-05-08
NO20011409L (no) 2001-03-28
HUP0103691A2 (hu) 2002-02-28
AP1456A (en) 2005-09-30
OA11653A (en) 2004-12-08
AP2001002102A0 (en) 2001-03-31
MY127939A (en) 2007-01-31

Similar Documents

Publication Publication Date Title
DE69929996D1 (de) Pharmazeutisches mittel zur behandlung von diabetes
ID30393A (id) Senyawa tienopirimidina, pembuatan dan penggunaannya
ID22852A (id) Bahan-bahan biokontrol antifungi, proses untuk membuatnya dan memperlakukannya
ATE285767T1 (de) Kombinationstherapie, enthaltend atorvastatin und bluddrucksenkendes mittel
ATE315927T1 (de) Haarbehandlungsmittel enthaltend partikuläre substanzen
ATE260652T1 (de) Arzneimittel und verfahren zur behandlung von aufmerksamkeitsstörungen und aufmerksamkeits- /hyperaktivitätsstörungen mit methylphenidat
DK1117645T3 (da) Arylsubstituerede propanolaminderivater, fremgangsmåder til fremstilling deraf, lægemidler indeholdende disse forbindelser og anvendelse deraf
EE200100179A (et) Farmatseutilised agendid Parkinsoni tõve, ADHD jamikroadenoomide raviks
ID21863A (id) Senyawa kinolin dan kinazolin yangberguna dalam terapi, khususnya dalam pengobatan heperplasia prostatik jinak
ID21332A (id) Metode dan komposisi untuk pengobatan dan pencegahan hiperurikemia
ID26707A (id) Katalisator untuk produksi-olefin dan metode produksi-olefin
EE03767B1 (et) Arüülglütsiinamiidi derivaadid, nende valmistamismeetod ja kasutamine ning farmatseutiline preparaat
DE69805853D1 (de) Modifizierte lithium-vanadium-oxidelektrodenmaterialien, produkte und verfahren
EE9800234A (et) Ravimeetod ja farmatseutiline kompositsioon
ID25898A (id) Pembungkus sterilisasi, penerapannya, dan metoda sterilisasi
DE69628162D1 (de) Polymermaterial, medizinisches material und flüssige polymerzusammensetzung
EE04681B1 (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
EP1117395A4 (en) COMPOUNDS FOR THE TREATMENT OF ESTROGEN-RELATED DISEASES, METHODS OF PRODUCTION AND METHODS OF USE
EE04263B1 (et) Farmatseutiline kompositsioon piperidinoalkanoolantihistamiini ja selle derivaatide biosaadavuse suurendamiseks ning allergiliste reaktsioonide raviks patsiendil
EA200101260A1 (ru) Способ изменения физико-химических и/или биологических свойств вещества
EE200200199A (et) N-guanidinoalküülamiid, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaat ning raviotstarbeline kasutamine
ID24173A (id) 1,2,3,4,5,6 heksahidro-2-6-metano-3-benzazosin-10-ol, proses pembuatan dan penggunannya untuk obat-obatan
PT1017388E (pt) Composicao farmaceutica contendo ibuprofeno e domperidona para o tratamento de enxaqueca
GB2341092B (en) Composition for the removal of biological and organic substances
ATE202130T1 (de) Behandelte kohlenstoffartige zusammensetzungen und verbesserte polymerzusammensetzungen